The precise use of immunotherapy agents in locally advanced head and neck squamous cell carcinoma has not been clearly ...

Neoadjuvant combination immunotherapy may improve survival compared with single-agent therapy for patients with head and neck squamous cell carcinoma, according to results of a randomized phase 2 ...

Copenhagen, Denmark - FluoGuide A/S ("FluoGuide" or the "Company"), a biotech company specializing in precision cancer surgery, is pleased to announce the inclusion of the first patient in its phase I ...

The FDA granted regenerative medicine advanced therapy designation to iltamciocel for patients with oropharyngeal dysphagia following head and neck cancer treatment.

Through an international joint research, a Korean research team developed the world's first pre-stage lesion (pre-cancer lesion) that implements the world's first pre-stage head and neck cancer lesion ...

Jim Stuckey is cancer-free after an extensive battle with head and neck cancer or oropharynx squamous cell carcinoma. To ...

Beth Riehle, a cancer patient, is using social media to show that life can still be full and meaningful, even after a ...

KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

Researchers at the University of Kentucky have introduced a novel microscopy technique that could revolutionize cancer research by providing an ...